Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
Patient-reported outcome and cognitive measures to be used in vascular and brain tumor surgery: proposal for a minimum set.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Schiavolin Silvia, Mariniello Arianna, Broggi Morgan, Abete-Fornara Giorgia, Bollani Alessandra, G Giulio Palmas, Bottini Gabriella, Querzola Matteo, Scarpa Pina, Casarotti Alessandra, De Michele Sara, Isella Valeria, Mauri Ilaria, Maietti Alessandra, Miramonti Valentina, Orru Maria Immacolata, Pertichetti Marta, Pini Elisa, Regazzoni Rossana, Subacchi Sara, Ferroli Paolo, Leonardi Matilde
Аннотация
BACKGROUND: The standardization of outcome measures is needed for comparing studies and using common measures in clinical practice. We aimed to identify cognitive and patient-reported outcomes and timing of assessment for glioma, meningioma, and vascular surgery.
METHOD: A consensus study was conducted. Participants selected cognitive and patient-reported measures among a list of instruments identified through a literature search.
RESULTS: Seventeen cognitive tests for the glioma and meningioma's evaluation, 8 for the vascular diseases, and one questionnaire on quality of life and one on emotional distress were identified. The timing of outcome assessment selected was before surgery, at discharge, and after 3 and 12 months for glioma; before surgery and after 3 months for meningioma; before surgery, at discharge, and after 6 months for vascular diseases.
CONCLUSION: The identification of common outcome measures is the first step toward a shared data collection improving the quality and comparability of future studies.
METHOD: A consensus study was conducted. Participants selected cognitive and patient-reported measures among a list of instruments identified through a literature search.
RESULTS: Seventeen cognitive tests for the glioma and meningioma's evaluation, 8 for the vascular diseases, and one questionnaire on quality of life and one on emotional distress were identified. The timing of outcome assessment selected was before surgery, at discharge, and after 3 and 12 months for glioma; before surgery and after 3 months for meningioma; before surgery, at discharge, and after 6 months for vascular diseases.
CONCLUSION: The identification of common outcome measures is the first step toward a shared data collection improving the quality and comparability of future studies.